The Potential Role of Probiotics in Cancer Prevention and Treatment

Nutrition and Cancer

Volumn 68, Issue 4, 2016, Pages 535-544

  Yu, Ai Qun ^a,b,c   Li, Lianqin ^d  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Shanghai Lida Polytechnic Institute   (China)

^d BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; PROBIOTIC AGENT; PROTECTIVE AGENT;

ANTINEOPLASTIC ACTIVITY; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; CANCER CELL LINE; CANCER PREVENTION; CLINICAL TRIAL (TOPIC); DNA DAMAGE; DRUG EFFECT; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; REVIEW; ANIMAL; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CLINICAL TRIALS AS TOPIC; DNA DAMAGE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROBIOTICS;

EID: 84965022947     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1158300     Document Type: Review

References (120)

1. FAO/WHO Working Group. London, Ontario, Canada: 2002. Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available online: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
2. M.L.Ritchie and T.N.Romanuk: A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7, e34938, 2012.
3. A.Zabala, M.R.Martín, A.I.Haza, L.Fernández, J.M.Rodríguez, et al.: Anti-proliferative effect of two lactic acid bacteria strains of human origin on the growth of a myeloma cell line. Lett Appl Microbiol 32, 287–292, 2001.
4. M.Thirabunyanon, P.Boonprasom, and P.Niamsup: Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol Lett 31, 571–576, 2009.
5. J.Grimoud, H.Durand, S.de Souza, P.Monsan, F.Ouarné, et al.: In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol 144, 42–50, 2010.
6. M.Thirabunyanon and P.Hongwittayakorn: Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol 169, 511–525, 2013.
7. A.Verma and G.Shukla: Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer 65, 84–91, 2013.
8. A.C.Ouwehand, S.Salminen, P.J.Roberts, J.Ovaska, and E.Salminen: Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa. Clin Diagn Lab Immunol 10, 643–646, 2003.
9. S.Ohkawara, H.Furuya, K.Nagashima, N.Asanuma, and T.Hino: Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr 135, 2878–2883, 2005.
10. M.Seal, Y.Naito, R.Barreto, A.Lorenzetti, P.Safran, et al.: Experimental radiotherapy-induced enteritis: a probiotic interventional study. J Dig Dis 8, 143–147, 2007.
11. M.Lopez, N.Li, J.Kataria, M.Russell, and J.Neu: Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells. J Nutr 138, 2264–2268, 2008.
12. C.Zhou, F.Z.Ma, X.J.Deng, H.Yuan, and H.S.Ma: Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World J Gastroenterol 14, 5090–5095, 2008.
13. S.Rokka, S.Myllykangas, and V.Joutsjoki: Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production. Scand J Immunol 68, 280–286, 2008.
14. S.B.Fang, H.Y.Shih, C.H.Huang, L.T.Li, C.C.Chen, et al.: Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells. Support Care Cancer 22, 1647–1654, 2014.
15. R.K.Le Leu, Y.Hu, I.L.Brown, R.J.Woodman, and G.P.Young: Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31, 246–251, 2010.
16. Y.Oh, M.S.Osato, X.Han, G.Bennett, and W.K.Hong: Folk yoghurt kills Helicobacter pylori. J Appl Microbiol 93, 1083–1088, 2002.
17. X.Chen, X.M.Liu, F.Tian, Q.Zhang, H.P.Zhang, et al.: Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells. J Food Sci 77, M9–14, 2012.
18. C.H.Kuo, S.S.Wang, C.Y.Lu, H.M.Hu, F.C.Kuo, et al.: Long-term use of probiotic-containing yogurts is a safe way to prevent helicobacter pylori: Based on a Mongolian gerbil's model. Biochem Res Int 2013, 594561, 2013.
19. V.Verhoeven, N.Renard, A.Makar, P.Van Royen, J.P.Bogers, et al.: Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. Eur J Cancer Prev 22, 46–51, 2013.
20. I.R.Rowland, C.J.Rumney, J.T.Coutts, and L.C.Lievense: Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19, 281–285, 1998.
21. S.Nakanishi, K.Kataoka, T.Kuwahara, and Y.Ohnishi: Effects of high amylose maize starch and Clostridium butyricum on metabolism in colonic microbiota and formation of azoxymethane-induced aberrant crypt foci in the rat colon. Microbiol Immunol 47, 951–958, 2003.
22. A.de Moreno de LeBlanc and G.Perdigón: Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 29, 15–24, 2005.
23. S.Ohkawara, H.Furuya, K.Nagashima, N.Asanuma, and T.Hino: Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in mice. Nutr Cancer 59, 92–98, 2007.
24. M.H.Yazdi, M.M.Soltan Dallal, Z.M.Hassan, M.Holakuyee, S.Agha Amiri, et al.: Oral administration of Lactobacillus acidophilus induces IL-12 production in spleen cell culture of BALB/c mice bearing transplanted breast tumour. Br J Nutr 104, 227–232, 2010.
25. J.W.Lee, J.G.Shin, E.H.Kim, H.E.Kang, I.B.Yim, et al.: Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 5, 41–48, 2004.
26. M.M.Kosiewicz, A.L.Zirnheld, and P.Alard: Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol 2, 180, 2011.
27. R.Paolillo, C.Romano Carratelli, S.Sorrentino, N.Mazzola, and A.Rizzo: Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int Immunopharmacol 9, 1265–1271, 2009.
28. J.S.Lee, N.S.Paek, O.S.Kwon, and K.B.Hahm: Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism. J Gastroenterol Hepatol 25, 194–202, 2010.
29. T.Ohara, K.Yoshino, and M.Kitajima: Possibility of preventing colorectal carcinogenesis with probiotics. Hepatogastroenterology 57, 1411–1415, 2010.
30. F.Russo, A.Orlando, M.Linsalata, A.Cavallini, and C.Messa: Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr Cancer 59, 106–114, 2007.
31. A.Orlando, C.Messa, M.Linsalata, A.Cavallini, and F.Russo: Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol 31, 108–116, 2009.
32. A.Orlando, M.G.Refolo, C.Messa, L.Amati, P.Lavermicocca, et al.: Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer 64, 1103–1111, 2012.
33. Y.Kim, D.Lee, D.Kim, J.Cho, J.Yang, et al.: Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch Pharm Res 31, 468–473, 2008.
34. E.L.Ma, Y.J.Choi, J.Choi, C.Pothoulakis, S.H.Rhee, et al.: The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer 127, 780–790, 2010.
35. Y.Kim, S.Oh, H.S.Yun, S.Oh, and S.H.Kim: Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells. Lett Appl Microbiol 51, 123–130, 2010.
36. A.Borowicki, A.Michelmann, K.Stein, D.Scharlau, K.Scheu, et al.: Fermented wheat aleurone enriched with probiotic strains LGG and Bb12 modulates markers of tumor progression in human colon cells. Nutr Cancer 63, 151–160, 2011.
37. K.Stein, A.Borowicki, D.Scharlau, A.Schettler, K.Scheu, et al.: Effects of synbiotic fermentation products on primary chemoprevention in human colon cells. J Nutr Biochem 23, 777–784, 2012.
38. F.J.Cousin, S.Jouan-Lanhouet, M.T.Dimanche-Boitrel, L.Corcos, and G.Jan: Milk fermented by Propionibacterium freudenreichii induces apoptosis of HGT-1 human gastric cancer cells. PLoS One 7, e31892, 2012.
39. J.Escamilla, M.A.Lane, and V.Maitin: Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer 64, 871–878, 2012.
40. M.K.Cha, D.K.Lee, H.M.An, S.W.Lee, S.H.Shin, et al.: Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Me 10, 72, 2012.
41. R.Azam, S.Ghafouri-Fard, M.Tabrizi, M.H.Modarressi, R.Ebrahimzadeh-Vesal, et al.: Lactobacillus acidophilus and Lactobacillus crispatus culture supernatants downregulate expression of cancer-testis genes in the MDA-MB-231 cell line. Asian Pac J Cancer Prev 15, 4255–4259, 2014.
42. M.Ghoneum and J.Gimzewski: Apoptotic effect of a novel kefir product, PFT, on multidrug-resistant myeloid leukemia cells via a hole-piercing mechanism. Int J Oncol 44, 830–837, 2014.
43. G.Jan, A.S.Belzacq, D.Haouzi, A.Rouault, D.Métivier, et al.: Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 9, 179–188, 2002.
44. C.Iyer, A.Kosters, G.Sethi, A.B.Kunnumakkara, B.B.Aggarwal, et al.: Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol 10, 1442–1452, 2008.
45. M.S.Castro, M.A.Molina, P.Di Sciullo, M.B.Azpiroz, F.Leocata Nieto, et al.: Beneficial activity of Enterococcus faecalis CECT7121 in the anti-lymphoma protective response. J Appl Microbiol 109, 1234–1243, 2010.
46. C.Baldwin, M.Millette, D.Oth, M.T.Ruiz, F.M.Luquet, et al.: Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis. Nutr Cancer 62, 371–378, 2010.
47. M.Shinnoh, M.Horinaka, T.Yasuda, S.Yoshikawa, M.Morita, et al.: Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8. Int J Oncol 42, 903–911, 2013.
48. G.H.McIntosh, P.J.Royle, and M.J.Playne: A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer 35, 153–159, 1999.
49. E.Park, G.I.Jeon, J.S.Park, and H.D.Paik: A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol Pharm Bull 30, 569–574, 2007.
50. N.K.Lee, J.S.Park, E.Park, and H.D.Paik: Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Lett Appl Microbiol 44, 274–278, 2007.
51. J.H.Chang, Y.Y.Shim, S.K.Cha, M.J.Reaney, and K.M.Chee: Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon. J Med Microbiol 61, 361–368, 2012.
52. R.S.Kumar, P.Kanmani, N.Yuvaraj, K.A.Paari, V.Pattukumar, et al.: Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1,2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166, 620–631, 2012.
53. Asha and D.Gayathri: Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in mice. Exp Ther Med 3, 1049–1054, 2012.
54. D.Mohania, V.K.Kansal, P.Kruzliak, and A.Kumari: Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin depleted foci and cell proliferation on 1, 2-dimethylhydrazine induced colorectal carcinogenesis in Wistar rats. Rejuvenation Res 7, 325–333, 2014.
55. K.Yamazaki, A.Tsunoda, M.Sibusawa, Y.Tsunoda, M.Kusano, et al.: The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep 7, 977–982, 2000.
56. A.P.Femia, C.Luceri, P.Dolara, A.Giannini, A.Biggeri, et al.: Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953–1960, 2002.
57. F.Marotta, Y.Naito, E.Minelli, H.Tajiri, J.Bertuccelli, et al.: Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study. Hepatogastroenterology 50, 1914–1918, 2003.
58. E.Klewicka, A.Nowak, Z.Zduńczyk, B.Cukrowska, and J.Błasiak: Protective effect of lactofermented beetroot juice against aberrant crypt foci formation and genotoxicity of fecal water in rats. Exp Toxicol Pathol 64, 599–604, 2012.
59. A.M.Urbanska, J.Bhathena, C.Martoni, and S.Prakash: Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice. Dig Dis Sci 54, 264–273, 2009.
60. X.Chen, J.Fruehauf, J.D.Goldsmith, H.Xu, K.K.Katchar, et al.: Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice. Gastroenterology 137, 914–923, 2009.
61. H.L.Zhang, L.X.Yu, W.Yang, L.Tang, Y.Lin, et al.: Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 57, 803–812, 2012.
62. C.Kaga, A.Takagi, M.Kano, S.Kado, I.Kato, et al.: Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer. Cancer Sci 104, 1508–1514, 2013.
63. M.Zhang, F.Wang, L.Jiang, R.Liu, L.Zhang, et al.: Lactobacillus salivarius REN inhibits rat oral cancer induced by 4-nitroquioline 1-oxide. Cancer Prev Res (Phila) 6, 686–694, 2013.
64. S.Demirer, S.Aydintug, B.Aslim, I.Kepenekci, N.Sengül, et al.: Effects of probiotics on radiation-induced intestinal injury in rats. Nutrition 22, 179–186, 2006.
65. L.D.Prisciandaro, M.S.Geier, R.N.Butler, A.G.Cummins, and G.S.Howarth: Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Cancer Biol Ther 11, 671–677, 2011.
66. F.S.Weill, E.M.Cela, M.L.Paz, A.Ferrari, J.Leoni, et al.: Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis. Br J Nutr 109, 457–466, 2013.
67. H.Urbancsek, T.Kazar, I.Mezes, and K.Neumann: Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 13, 391–396, 2001.
68. J.Giralt, J.P.Regadera, R.Verges, J.Romero, I.de la Fuente, et al.: Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 71, 1213–1219, 2008.
69. P.Delia, G.Sansotta, V.Donato, G.Messina, P.Frosina, et al.: Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience. Dig Liver Dis 34 (Suppl 2), S84–86, 2002.
70. P.Delia, G.Sansotta, V.Donato, P.Frosina, G.Messina, et al.: Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 13, 912–915, 2007.
71. I.Chitapanarux, T.Chitapanarux, P.Traisathit, S.Kudumpee, E.Tharavichitkul, et al.: Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 5, 31, 2010.
72. J.Zwielehner, C.Lassl, B.Hippe, A.Pointner, O.J.Switzeny, et al.: Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One 6, e28654, 2011.
73. P.Osterlund, T.Ruotsalainen, R.Korpela, M.Saxelin, A.Ollus, et al.: Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 97, 1028–1034, 2007.
74. M.Wada, S.Nagata, M.Saito, T.Shimizu, Y.Yamashiro, et al.: Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18, 751–759, 2010.
75. G.Sugawara, M.Nagino, H.Nishio, T.Ebata, K.Takagi, et al.: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 244, 706–714, 2006.
76. T.Nomura, Y.Tsuchiya, A.Nashimoto, H.Yabusaki, Y.Takii, et al.: Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 54, 661–663, 2007.
77. L.Gianotti, L.Morelli, F.Galbiati, S.Rocchetti, S.Coppola, et al.: A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol 16, 167–175, 2010.
78. Z.Liu, H.Qin, Z.Yang, Y.Xia, W.Liu, et al.: Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery-a double-blind study. Aliment Pharmacol Ther 33, 50–63, 2011.
79. S.Ohigashi, Y.Hoshino, S.Ohde, and H.Onodera: Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surg Today 41, 1200–1206, 2011.
80. J.W.Zhang, P.Du, J.Gao, B.R.Yang, W.J.Fang, et al.: Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am J Med Sci 343, 199–205, 2012.
81. Z.H.Liu, M.J.Huang, X.W.Zhang, L.Wang, N.Q.Huang, et al.: The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. Am J Clin Nutr 97, 117–126, 2013.
82. H.S.El-Nezami, N.N.Polychronaki, J.Ma, H.Zhu, W.Ling, et al.: Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr 83, 1199–1203, 2006.
83. J.Rafter, M.Bennett, G.Caderni, Y.Clune, R.Hughes, et al.: Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85, 488–496, 2007.
84. M.J.Bonorden, K.A.Greany, K.E.Wangen, W.R.Phipps, J.Feirtag, et al.: Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr 58, 1635–1642, 2004.
85. J.A.Nettleton, K.A.Greany, W.Thomas, K.E.Wangen, H.Adlercreutz, et al.: Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 134, 1998–2003, 2004.
86. H.Ishikawa, I.Akedo, T.Otani, T.Suzuki, T.Nakamura, et al.: Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116, 762–767, 2005.
87. C.G.Campbell, B.P.Chew, L.O.Luedecke, and T.D.Shultz: Yogurt consumption does not enhance immune function in healthy premenopausal women. Nutr Cancer 37, 27–35, 2000.
88. M.Toi, S.Hirota, N.Tomotaki A,Sato, Y.Hozumi, et al.: Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study. Curr Nutr Food Sci 9, 194–200, 2013.
89. G.Reid, J.Jass, M.T.Sebulsky, and J.K.McCormick: Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16, 658–672, 2003.
90. L.O'Mahony, M.Feeney, S.O'Halloran, L.Murphy, B.Kiely, et al.: Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15, 1219–1225, 2001.
91. I.Eizaguirre, N.G.Urkia, A.B.Asensio, I.Zubillaga, P.Zubillaga, et al.: Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg 37, 699–702, 2002.
92. A.L.Apás, J.Dupraz, R.Ross, S.N.González, and M.E.Arena: Probiotic administration effect on fecal mutagenicity and microflora in the goat's gut. J Biosci Bioeng 110, 537–540, 2010.
93. K.Hatakka, R.Holma, H.El-Nezami, T.Suomalainen, M.Kuisma, et al.: The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128, 406–410, 2008.
94. L.J.Brady, D.D.Gallaher, and F.F.Busta: The role of probiotic cultures in the prevention of colon cancer. J Nutr 130, 410–414, 2000.
95. T.Odamaki, H.Sugahara, S.Yonezawa, T.Yaeshima, K.Iwatsuki, et al.: Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota. Anaerobe 18, 14–18, 2012.
96. D.M.Commane, C.T.Shortt, S.Silvi, A.Cresci, R.M.Hughes, et al.: Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 51, 102–109, 2005.
97. J.S.Ko, H.R.Yang, J.Y.Chang, and J.K.Seo: Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha. World J Gastroenterol 13, 1962–1965, 2007.
98. C.Jones, S.A.Badger, M.Regan, B.W.Clements, T.Diamond, et al.: Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v. Eur J Gastroenterol Hepatol 25, 1424–1430, 2013.
99. S.Ahrne and M.L.Hagslatt: Effect of lactobacilli on paracellular permeability in the gut. Nutrients 3, 104–107, 2011.
100. H.Horie, M.Zeisig, K.Hirayama, T.Midtvedt, L.Möller, et al.: Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9H-pyrido[2,3-b]indole in a human-flora associated mouse model. Eur J Cancer Prev 12, 101–107, 2003.
101. D.L.Oberreuther-Moschner, G.Jahreis, G.Rechkemmer, and B.L.Pool-Zobel: Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br J Nutr 91, 925–932, 2004.
102. S.L.Yeh, M.S.Lin, and H.L.Chen: Inhibitory effects of a soluble dietary fiber from Amorphophallus konjac on cytotoxicity and DNA damage induced by fecal water in Caco-2 cells. Planta Med 73, 1384–1388, 2007.
103. A.Kumar, N.K.Singh, and P.R.Sinha: Inhibition of 1,2-dimethylhydrazine induced colon genotoxicity in rats by the administration of probiotic curd. Mol Biol Rep 37, 1373–1376, 2010.
104. L.D.Prisciandaro, M.S.Geier, A.E.Chua, R.N.Butler, A.G.Cummins, et al.: Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage. Support Care Cancer 20, 3205–3210, 2012.
105. R.K.Le Leu, I.L.Brown, Y.Hu, A.R.Bird, M.Jackson, et al.: A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr 135, 996–1001, 2005.
106. X.P.Zhang, F.Liu, Z.Cheng, and W.Wang: Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci USA 106, 12245–12250, 2009.
107. K.Takeda and K.Okumura: Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137 (Suppl 2), 791S–793S, 2007.
108. M.Roller, Y.Clune, K.Collins, G.Rechkemmer, and B.Watzl: Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr 97, 676–684, 2007.
109. A.Takagi, T.Matsuzaki, M.Sato, K.Nomoto, M.Morotomi, et al.: Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22, 599–605, 2001.
110. M.Roller, A.Pietro Femia, G.Caderni, G.Rechkemmer, and B.Watzl: Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 92, 931–938, 2004.
111. A.de Moreno de LeBlanc, C.Matar, C.Thériault, and G.Perdigón: Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology 210, 349–458, 2005.
112. J.Bassaganya-Riera, M.Viladomiu, M.Pedragosa, C.De Simone, and R.Hontecillas: Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7, e34676, 2012.
113. H.Maroof, Z.M.Hassan, A.M.Mobarez, and M.A.Mohamadabadi: Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol 32, 1353–1359, 2012.
114. J.R.Lakritz, T.Poutahidis, T.Levkovich, B.J.Varian, Y.M.Ibrahim, et al.: Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer 135, 529–540, 2014.
115. N.P.Foo, H.Ou Yang, H.H.Chiu, H.Y.Chan, C.C.Liao, et al.: Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem 59, 13337–13345, 2011.
116. J.T.Nurmi, P.A.Puolakkainen, and N.E.Rautonen: Bifidobacterium Lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr Cancer 51, 83–92, 2005.
117. J.B.Ewaschuk, J.W.Walker, H.Diaz, and K.L.Madsen: Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 136, 1483–1487, 2006.
118. S.Matsumoto, T.Hara, M.Nagaoka, A.Mike, K.Mitsuyama, et al.: A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer. Immunology 128 (Suppl 1), e170–180, 2009.
119. C.B.Appleyard, M.L.Cruz, A.A.Isidro, J.C.Arthur, C.Jobin, et al.: Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol 301, G1004–1013, 2011.
120. 1-induced liver carcinogenesis in rats. Br J Nutr 107, 1006–1016, 2012.